Canadian drug makers hit with $1.1B suit for pushing opioids despite risks

TORONTO — Canadian drug makers enriched themselves at the expense of vulnerable patients by illegally and deceptively promoting highly addictive opioids that have killed thousands in recent years, a proposed class action filed Wednesday asserts.